FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting
Go back to FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting| (NASDAQ: FBLG) | Delayed: 0.81 +0.04 (5.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $ | |||
| Open | $0.76 | 52 Week Low | $ | |||
| Day High | $0.82 | P/E | N/A | |||
| Day Low | $0.75 | EPS | $ | |||
| Volume | 158,133 | |||||

